The end of the enrollment for the pediatrics study

15 November 2006

OCT is glad to inform about the successful enrollment of 600 patients at 7 sites during 6 weeks for the pediatrics study carried out for one of the leaders in the foodstuff industry.

OCT Vision

“OCT vision is to be recognized by pharmaceutical and biotech companies as a leading provider of clinical trials in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic. OCT is able to support any requirements that clients may have in the region, ranging from one-off advice to full-study implementation and execution. We are determined and decisive in expanding our activity at this rapidly growing market”— Dmitry Sharov, General Manager of OCT.